Trends Driving the $5 Billion Mobile ECG Devices Market, 2030 - Rising Use in Telemedicine Applications Propels Adoption
Understand the significant growth trajectory of the Handheld ECG Devices segment, which is expected to reach US$1.9 Billion ...
MassDevice13d
AliveCor wins CMS reimbursement for 12-lead ECG
AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...
PharmiWeb1d
Atrial Fibrillation Device Market: Growth, Trends, and Future Outlook
The atrial fibrillation (AF) device market is experiencing rapid growth, fueled by the rising prevalence of atrial fibrillation, increasing awareness of early diagnosis, and advancements in medical ...
Biomednewsbreaks Heartbeam Inc. (NASDAQ: BEAT) Submits FDA Application For 12-Lead ECG Synthesis Software
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
Taiwan News18d
ECG Devices Market Growing Trade Among Emerging Economies Opening New Opportunities
Their ECG devices range from portable handheld monitors to advanced telemetry systems, catering to the diverse needs of industrial settings such as manufacturing plants, warehouses, and logistics ...
HeartBeam seeks FDA nod for ECG synthesis software
SANTA CLARA, Calif. - HeartBeam, Inc. (NASDAQ: BEAT), a $56.5 million market cap pioneer in medical technology currently trading at $2.12 per share, has announced the submission of a 510(k) ...